NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/18/2025
Back to search
Official data from USPTO
PE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
03/18/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 44
Filing date
11/02/2023
Registration date
03/18/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2025
Last transaction
03/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/18/2024
First use in commerce
04/18/2024
Drawing code
5
Owner type
03
Owner location
Tucson, AZ, US
Examiner
SAXTON,EVELYN H
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized letters "PE" where the "P" is over and to the left of the "E", where the fill of the "P" being a gradient and the fill of the "E" being a gradient, the letters combining to form a hexagonal design.
Holders and representatives
Holders
Precision Epigenomics, Inc.
Representatives
Eugene Vamos Law Office of Eugene Vamos, PLLC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancer; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of cancer
Class 44
Cancer screening services; Medical screening; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnostic testingmonitoring and reporting services; Medical testing services relating to the diagnosis and treatment of disease
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/28/2025
PUBO
PUBLISHED FOR OPPOSITION
01/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2025
IUAA
USE AMENDMENT ACCEPTED
01/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2024
GNRT
NON-FINAL ACTION E-MAILED
09/16/2024
CNRT
NON-FINAL ACTION WRITTEN
09/16/2024
DOCK
ASSIGNED TO EXAMINER
06/12/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/03/2024
IUAF
USE AMENDMENT FILED
05/03/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/21/2024
NWAP
NEW APPLICATION ENTERED
11/03/2023
Continuous trademark protection
Get notified about every new filing that threatens PE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.